Archives

Protease-activated receptor-2 protects against influenza virus through IFN-gamma pathway

Pathways:

IFN-gamma pathway

Host Molecules Involved:

Protease-activated receptor-2 (PAR(2)), associated with inflammation at mucosal surfaces.

Tissues:

Respiratory tract, mucosal surfaces, bronchoalveolar lavages

Systems:

Lungs, immune system

Interactions:

PAR(2) enhances IFN- gamma production.

Mechanisms:

In vitro, PAR(2) inhibits influenza virus type A (IAV) replication through the production of IFN-gamma.
In [...]

M1 blocks the complement pathway

Pathways:

The complement pathway

Influenza Molecules Involved:

The matrix (M1) protein of influenza A virus regulates the viral life cycle.

Host Molecules Involved:

Complement C1qA

Tissues:

Lung

Systems:

Host innate immune system

Interactions:

M1 interacts with complement C1qA, inhibits the classical complement pathway.

Mechanisms:

The N-terminal domain of M1 protein is needed for binding to the globular [...]

RARRES3

Gene:

RARRES3

Full Name:

retinoic acid receptor responder (tazarotene induced) 3 [Homo sapiens]

Other Symbols:

HRASLS4, MGC8906, PLA1/2-3, RIG1, TIG3

Other Names:

retinoic acid-inducible gene 1

Chromosome Location:

11q23

OMIMID:

605092

GeneID: 5920

Sequences:

Nucleotide
Protein

Human-Influenza Interactions:

RIG-I is needed for inducing IFN-I in an influenza A virus (IAV)-infected human lung epithelial cell line.

(http://www.ncbi.nlm.nih.gov/pubmed/17053203)

Copyright © 2009 PharmTao.com. All Rights Reserved.
Disclaimer: By using this site, the readers agree that the content on our web pages is for information purpose only. The information provided on our web pages is not intended for diagnosis, or to treat, cure or prevent any diseases, conditions or symptoms, or to do experiments, or to endorse any products. Personal directions and the use of health and biomedical products should be provided by qualified health professionals.